Page last updated: 2024-09-05

lapatinib and miglitol

lapatinib has been researched along with miglitol in 2 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(miglitol)
Trials
(miglitol)
Recent Studies (post-2010) (miglitol)
1,9193051,44226988115

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)miglitol (IC50)
Maltase-glucoamylase, intestinalHomo sapiens (human)4.4667
Lysosomal alpha-glucosidaseHomo sapiens (human)1.1167
Sucrase-isomaltase, intestinalHomo sapiens (human)0.5
Sucrase-isomaltase, intestinalRattus norvegicus (Norway rat)1.3343
Glycogen debranching enzymeOryctolagus cuniculus (rabbit)0.39
Lysosomal alpha-glucosidaseRattus norvegicus (Norway rat)1.1225

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chen, L; Gao, H; Li, B; Li, X; Liu, J; Liu, R; Wang, W; Zhang, Y; Zhao, L1

Reviews

1 review(s) available for lapatinib and miglitol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for lapatinib and miglitol

ArticleYear
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase.
    Bioorganic & medicinal chemistry letters, 2017, 09-15, Volume: 27, Issue:18

    Topics: 1-Deoxynojirimycin; alpha-Glucosidases; Dose-Response Relationship, Drug; ErbB Receptors; Glycoside Hydrolase Inhibitors; Humans; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship

2017